GlassScriptPhysician profile
Jordan E Jutras
NPI 1821726803
$775.24
in general payments reported to CMS, 2019-2025
18 companies · $246 in 2025
The $246 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $34.36 · 2023: $225 · 2024: $270 · 2025: $246.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $741.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $740.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $137.43 | 2023-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $108.50 | 2022-2025 | Xifaxan, Trulance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $66.42 | 2022-2024 | Ofev |
| Glaxosmithkline, LLC. | $65.11 | 2023-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Pfizer INC. | $61.74 | 2024-2025 | |
| Mylan Specialty L.P. | $48.55 | 2023-2024 | Yupelri |
| Novo Nordisk INC | $42.18 | 2023-2024 | Wegovy |
| Astrazeneca Pharmaceuticals LP | $39.10 | 2025 | Farxiga, Breztri |
| Amgen INC. | $33.40 | 2024-2025 | Evenity, Prolia |
| Lundbeck LLC | $31.96 | 2023 | Rexulti |
| Corcept Therapeutics | $23.38 | 2024 | Korlym |
| Antares Pharma, INC. | $20.81 | 2025 | Xyosted |
| Alnylam Pharmaceuticals INC. | $17.50 | 2024 | Onpattro |
| Aimmune Therapeutics, INC. | $17.30 | 2025 | Vowst |
| Krystal Biotech INC | $16.21 | 2025 | Vyjuvek |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $15.77 | 2025 | |
| Lilly USA, LLC | $15.69 | 2025 | Kisunla |
| Bayer Healthcare Pharmaceuticals INC. | $14.19 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jordan Jutras listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.